Kevin Bitterman

Photo of Kevin Bitterman, Partner at Polaris Partners
CompanyDeal TypeAmountDate
Akero TherapeuticsSeries A$65M (Lead)Jun 2018
NeuroneticsSeries G$15MJun 2017
VisterraSeries C$23.1MJun 2016
Kala PharmaceuticalsSeries C$68MApr 2016
PulmatrixPost-IPO Equity$10MJun 2015
Arsenal MedicalVenture Round$16M (Lead)Jun 2015
NeuroneticsSeries F$34.3MApr 2015
VisterraSeries B$30MOct 2014
Kala PharmaceuticalsSeries B$22.5MApr 2014
VisterraSeries A$8.1MDec 2013
No media found for Kevin Bitterman.
cb
Photo of Alan Crane, Partner at Polaris Partners

Polaris Partners

AN

Polaris Partners

Photo of Amy Schulman, Venture Partner at Polaris Partners

Polaris Partners

Photo of Brian Chee, Managing Partner at Polaris Partners

Polaris Partners

Photo of Bryce Youngren, Managing Partner at Polaris Partners

Polaris Partners